BM
BlackRock Health Sciences Trust
BME · NYSE
$44.49 -0.02% (-$0.01)
1M -3.56%
Market Cap $569.6M
P/E Ratio 7.40x
Div. Yield 7.14%
ROE 12.74%
Bulios Fair Price
$45.14
1.5% upside
Current Price
$44.49
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BME is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
75 /100
Cheap P/E 7.40x
P/S 15.75x
P/B 1.00x
Growth
14 /100
Declining Book val. growth 1.80%
EPS growth N/A
Rev. growth N/A
Profitability
100 /100
Strong Net margin 212.86%
Op. margin 212.94%
Gross margin N/A
Quality
87 /100
Excellent ROE 12.74%
ROA 13.50%
Asset turnover 0.06x
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
20 /100
Unstable Beta 0.59x
Rev. volatility 135.98%
EPS volatility 108.25%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BME
Online
Sector
Financial Services
Industry
Asset Management
CEO
John Perlowski
Employees
-
Headquarters
New York
Upcoming events
15 OCT
Ex-Dividend
Ex-dividend date
30 OCT
Dividend Payment
Payment date
13 NOV
Ex-Dividend
Ex-dividend date
30 NOV
Dividend Payment
Payment date
11 DEC
Ex-Dividend
Ex-dividend date
22 DEC
Dividend Payment
Payment date